DEFIANCE Act of 2025
Summary
The DEFIANCE Act of 2025 (S1837) expands federal civil remedies for nonconsensual intimate images and creates a new private right of action for deepfakes. The bill passed the Senate unanimously and is now held at the House desk. It authorizes no government spending and imposes no direct compliance costs on publicly traded companies, resulting in negligible near-term market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The DEFIANCE Act creates no government spending or procurement; market impact is near zero.
- 2.No public company faces direct compliance costs or revenue opportunity from this bill.
- 3.Legislative momentum is strong (unanimous Senate passage), but the bill's scope is limited to civil liability expansion.
Market Implications
The DEFIANCE Act does not alter any company's revenue, cost structure, or competitive dynamics. It is a procedural liability bill with no appropriations or mandates. Any market reaction would be purely noise. Investors should ignore this bill for portfolio decisions. No tickers are relevant.
Full Analysis
The DEFIANCE Act (S1837) is a targeted liability bill. It amends existing civil remedies for nonconsensual pornography and creates a new federal cause of action against persons who create or distribute intimate digital forgeries (deepfakes) without consent. The bill does not appropriate any funds, mandate procurement, or impose regulatory standards on specific industries. It is a private right of action: victims may sue for damages, injunctive relief, and litigation costs.
No public company is directly obligated by this bill. The legal risk it creates falls on individuals and potentially on platform hosts if they are deemed distributors. However, Section 230 of the Communications Decency Act remains unchanged, limiting liability for platforms. The bill does not require any specific technology deployment, compliance investment, or behavioral change from corporations. As a result, there is no identifiable revenue or cost impact on any publicly traded company.
The legislative momentum is high—passed the Senate unanimously—but the substance is narrow. The companion bill (HR3562) is still in House committee. Even if enacted, the market effect is minimal because the bill does not create a spending program, tax credit, or procurement directive. Structural winners and losers are not identifiable through any public equity lens.
Timeline: The bill has cleared the Senate; now awaits House action. Given unanimous Senate support and a companion bill, passage is plausible but timing is uncertain. No further legislative steps are defined.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
HII MISSION TECHNOLOGIES CORP: $579M General Services Administration Contract
VERTEX AEROSPACE LLC: $513M General Services Administration Contract
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION: $557M General Services Administration Contract
HII MISSION TECHNOLOGIES CORP: $579M General Services Administration Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Establishing an America First Arms Transfer Strategy
This executive order directs the Secretary of War, along with the Secretaries of State and Commerce, to create an 'America First Arms Transfer Strategy' that prioritizes foreign arms sales to boost U.S. defense industrial base capacity, streamline export processes, and enhance production of key weapons systems. It mandates a sales catalog of prioritized platforms within 120 days, forms a task force to improve coordination, and reforms congressional notification procedures for arms transfers.
Ushering in the Next Frontier of Quantum Innovation
This executive order updates the National Quantum Strategy and establishes a national effort (QC-ADDS) to develop a quantum computer for scientific discovery, with deployment at a Department of Energy facility. It directs multiple agencies to prioritize quantum sensing, networking, and supply chain initiatives, and mandates plans for commercial readiness and national security applications.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →